- Home
- ASBP vs MTEX Comparison
ASBP vs MTEX Comparison
Compare ASBP & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASBP
- MTEX
- Stock Information
- Founded
- ASBP 2021
- MTEX 1993
- Country
- ASBP United States
- MTEX United States
- Employees
- ASBP N/A
- MTEX N/A
- Industry
- ASBP Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- ASBP Health Care
- MTEX Health Care
- Exchange
- ASBP Nasdaq
- MTEX Nasdaq
- Market Cap
- ASBP 18.7M
- MTEX 15.8M
- IPO Year
- ASBP N/A
- MTEX 1999
- Fundamental
- Price
- ASBP $0.33
- MTEX $8.46
- Analyst Decision
- ASBP
- MTEX
- Analyst Count
- ASBP 0
- MTEX 0
- Target Price
- ASBP N/A
- MTEX N/A
- AVG Volume (30 Days)
- ASBP 40.8M
- MTEX 50.8K
- Earning Date
- ASBP 11-24-2025
- MTEX 11-11-2025
- Dividend Yield
- ASBP N/A
- MTEX N/A
- EPS Growth
- ASBP N/A
- MTEX N/A
- EPS
- ASBP N/A
- MTEX N/A
- Revenue
- ASBP N/A
- MTEX $112,975,000.00
- Revenue This Year
- ASBP N/A
- MTEX N/A
- Revenue Next Year
- ASBP N/A
- MTEX N/A
- P/E Ratio
- ASBP N/A
- MTEX N/A
- Revenue Growth
- ASBP N/A
- MTEX N/A
- 52 Week Low
- ASBP $0.20
- MTEX $7.22
- 52 Week High
- ASBP $15.80
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- ASBP 43.96
- MTEX 49.54
- Support Level
- ASBP $0.31
- MTEX $8.60
- Resistance Level
- ASBP $0.37
- MTEX $12.00
- Average True Range (ATR)
- ASBP 0.06
- MTEX 0.79
- MACD
- ASBP 0.00
- MTEX 0.02
- Stochastic Oscillator
- ASBP 47.29
- MTEX 14.78
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.